6th Neurodegenerative Conditions Research and Development
Conference - San Francisco, CA
Following on the heels of success with our previous five Neurodegenerative Diseases Drug Discovery conferences, we are proud to bring another comprehensive and timely summit, the 6th Neurodegenerative Conditions Research and Development on Sept 13-14, 2012 in San Francisco, CA.
The drug discovery effort for neurodegenerative diseases has been one of the major challenges and focuses of the pharmaceutical industry, which has been evidenced by fast and dynamic research and development in this field. Though several clinical trials for Alzheimer's failed in the last couple of years, there has been great progress in the development of novel therapeutic approaches and targets to treat Alzheimer’s as well as Parkinson’s, Huntington’s, multiple sclerosis, stroke and various other neurodegenerative diseases. Some of these novel approaches include biomarkers, stem cell therapy, protein misfolding and aggregation, immunotherapy, vaccines for Alzheimer's, BACE inhibitors, and much more. There have also been significant developments in our understanding of the genetics, the molecular mechanisms and signaling pathways contributing to neuronal dysfunction, neurotoxicity and pathology.
(Courtesy of http://www.gtcbio.com/component/)
Thu, Sep 13, 2012 - Fri, Sep 14, 2012
San Fracisco, CA, Hilton San Francisco Financial District
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
